Market Closed -
Nasdaq
21:00:00 14/06/2024 BST
5-day change
1st Jan Change
1.055
USD
-6.64%
-4.09%
-57.80%
Presentation Operator MessageOperator (Operator)Greetings. Welcome to the Ekso Bionics First Q...
Transcript : Ekso Bionics Holdings, Inc., Q1 2024 Earnings Call, Apr 29, 2024
04-29
Ekso Bionics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
04-29
CI
Earnings Flash (EKSO) EKSO BIONICS HOLDINGS Posts Q1 Revenue $3.8M, vs. Street Est of $5M
04-29
MT
Certain Warrants of Ekso Bionics Holdings, Inc. are subject to a Lock-Up Agreement Ending on 17-MAR-2024.
03-16
CI
Certain Common Stock of Ekso Bionics Holdings, Inc. are subject to a Lock-Up Agreement Ending on 17-MAR-2024.
03-16
CI
HC Wainwright Trims Price Target on Ekso Bionics to $9.25 From $10, Keeps Buy Rating
03-05
MT
Transcript : Ekso Bionics Holdings, Inc., Q4 2023 Earnings Call, Mar 04, 2024
03-04
Ekso Bionics Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
03-04
CI
Ekso Bionics Holdings, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
03-04
CI
HC Wainwright Adjusts Ekso Bionics Holdings' Price Target to $10 From $9, Keeps Buy Rating
01-22
MT
Ekso Bionics Holdings, Inc. Launches GaitCoach Software for EksoNR
01-08
CI
Ekso Bionics Holdings, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2023
01-04
CI
Ekso Bionics Holdings, Inc. Receives CMS Coding Approval for Ekso Indego Personal
12-12
CI
Transcript : Ekso Bionics Holdings, Inc., Q3 2023 Earnings Call, Oct 26, 2023
26/10/23
Earnings Flash (EKSO) EKSO BIONICS HOLDINGS Posts Q3 Revenue $4.6M, vs. Street Est of $4.53M
26/10/23
MT
Ekso Bionics Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
26/10/23
CI
Transcript : Ekso Bionics Holdings, Inc., Q2 2023 Earnings Call, Jul 27, 2023
27/07/23
Earnings Flash (EKSO) EKSO BIONICS HOLDINGS Reports Q2 Revenue $4.7M, vs. Street Est of $4.35M
27/07/23
MT
Ekso Bionics Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
27/07/23
CI
Transcript : Ekso Bionics Holdings, Inc., Q1 2023 Earnings Call, Apr 27, 2023
27/04/23
Ekso Bionics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
27/04/23
CI
Earnings Flash (EKSO) EKSO BIONICS HOLDINGS Posts Q1 Revenue $4.1M, vs. Street Est of $2.8M
27/04/23
MT
Ekso Bionics Holdings, Inc. Announces Resignation of Stanley Stern from the Board, Effective on April 26, 2023
26/04/23
CI
Transcript : Ekso Bionics Holdings, Inc., Q4 2022 Earnings Call, Mar 28, 2023
28/03/23
Ekso Bionics Holdings, Inc Announces Director Changes
09/12/22
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves multiple markets and can be utilized both by able-bodied persons and persons with physical disabilities or impairments. Its products include EksoNR, which is a wearable robotic exoskeleton specifically designed to be used in a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower-limb powered exoskeleton; Ekso Indego Personal is a lightweight powered lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. The Company enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate and to walk again; assist individuals with a range of upper extremity impairments and allow industrial workers to perform difficult repetitive work for extended periods. Its segments include EksoHealth and EksoWorks.
More about the company
Last Close Price
1.055
USD
Average target price
10
USD
Spread / Average Target
+847.87%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1